Excel Life Sciences and Investigator Support Services Announce Clinical Research Partnership

Dec. 18, 2008, Chicago, IL - Excel Life Sciences (ELS),and contact information for the most appropriate
a U.S.-based, India-focused provider ofinvestigators. Sponsors and CROs negotiate budgets
comprehensive trial management services announcesand contracts with site personnel, make the final
that it has formed a partnership with Chicago-basedselection decision, and remit payment directly to
Investigator Support Services (ISS) to helpparticipating sites.
biopharmaceutcal companies and CROs identify“For 16 years, ISS has supported drug
investigative sites in India for their clinical researchdevelopment in by matching clinical trials with qualified
studies.investigators. Each year we successfully place sites
ELS has one of the largest networks of investigativeon nearly 250 studies for more than 80 sponsors and
sites in India with over 1,000 investigators and 700CROs in the United States, and we are excited to
sites. Each site has undergone an extensive dueexpand our reach to India in support of global clinical
diligence visit and review by ELS to determine itsresearch,” said Sarah Ebner, President,
experience and capabilities before they are acceptedInvestigator Support Services.
into the ELS network, enabling ELS to find the mostAbout Excel Life Sciences
qualified investigative sites for customers. In threeHeadquartered in Chicago, IL with offices in Boston,
recent studies, sponsors selected 100%, 80% andRaleigh-Durham, Washington DC, Hyderabad, Mumbai,
100% of sites recommended by ELS for the study.New Delhi and 21 other locations across India, ELS is
“We are very excited to be partnering with ISSone of the most experienced and fastest growing
to help their customers identify appropriatetrial management and site support organizations in
investigative sites in India. We are confident thatIndia, offering customized clinical trial solutions
together we can help more companies enter intoincluding: regulatory consulting, preparations,
India and run successful, on-time clinical studies,”submissions and query resolution; site identification
said Dr. Vijai Kumar, President and Chief Medicaland selection; patient recruitment and retention;
Officer, Excel Life Sciences.training of all clinical research stakeholders; technology
ISS represents 400 experienced sites with capabilitiestransfer; product licensing and more.
to conduct phase I-IV drug and device studies in allELS has one of the most experienced and respected
medical specialties.. All sites pass a quality review priorclinical operations teams in India with over 125 years
to inclusion in the ISS network and are furtherof collective experience in conducting more than 350
pre-qualified for individual studies based on protocolglobal and domestic trials at hundreds of sites and
requirements. At no cost to industry sponsors andwith thousands of patients. ELS has also trained over
CROs, ISS quickly provides study related documents1,500 clinical research personnel in India.